Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...

A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible ...

Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through ...

The retail giant’s move comes as more employers seek better care options and are paying particular attention to cancer ...

Walmart’s employees and their dependents are being offered expanded cancer treatment with doctors at the Mayo Clinic through the retailer’s insurance coverage.

Hot on the tail of AstraZeneca’s Imfinzi, Bristol Myers Squibb’s PD-1/L1 inhibitor Opdivo has expanded its non-small cell lung cancer (NSCLC) net with an ...

The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with resectable NSCLC.

[¹⁷⁷Lu]PSMA is a theranostic treatment that combines both therapeutics and diagnostics to target prostate-specific membrane antigens (PSMA) found in cancer cells. Compared to standard ...

Walmart is expanding its insurance coverage to offer advanced cancer treatment for employees and their dependents at the Mayo ...

About three months from opening, the the new Nebraska Medicine cancer facility in Kearney now has a name: Nebraska Medicine ...